Skip to main content

Greenberg Traurig Attorneys Trevor Chaplick and Daniel Smulian to Present at DeviceTalks Minnesota

BOSTON — June 3, 2016 — Trevor J. Chaplick and Daniel I.A. Smulian, shareholders with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks Minnesota, June 6, 2016, at the Science Museum of Minnesota in Saint Paul.

From 4:45 p.m. to 6:15 p.m., Chaplick, a shareholder in Greenberg Traurig’s Corporate & Securities Group in Washington, D.C., will moderate the panel discussion, “Hot topics: M&A, IP, and Products Liability Trends Impacting MedTech Companies.” He will be joined by Smulian, New York shareholder in the firm’s Litigation Practice and a member of the firm's Pharmaceutical, Medical Device & Health Care Litigation Group, as well as Ryan Kaeding, Vice President, Investment Banking, Piper Jaffray & Co., and John Burtis, patent attorney. Specific topics include:

  • M&A trends from the perspective of both acquirer and seller;
  • Financing best practices from early stage to exit;
  • Why IP protection is key to a successful exit; and
  • Recent developments in products liability litigation – the good, the bad, and the ugly.

Hosted by online journal, DeviceTalks is a conversation among leaders. It’s an evening for an exchange of ideas, insight, and contacts among the pioneers of the medical technology industry. Formerly known as the Big 100, this event is held annually in Boston, Orange County, Raleigh, and the Twin Cities.

About Greenberg Traurig, LLP

Greenberg Traurig, LLP (GTLaw) has more than 2,000 attorneys in 38 offices in the United States, Latin America, Europe, Asia and the Middle East and is celebrating its 50th anniversary. One firm worldwide, GTLaw has been recognized for its philanthropic giving, was named the largest firm in the U.S. by Law360 in 2017, and among the Top 20 on the 2016 Am Law Global 100. Web: Twitter: @GT_Law.